Immunomic Therapeutics
PrivateLast Round
VC Round
Jan 14, 2021
Total Funding Raised
$15.53M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Immunomic Therapeutics is a biotechnology company that develops nucleic acid-based vaccines and immunotherapies for oncology, infectious diseases, and allergies using its proprietary UNITE platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts, Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Immunomic Therapeutics Comparables
Compare Immunomic Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| MimiVax Inc. | 81% | |
| Takis S.r.l. | 78% | |
| Elicio Therapeutics | 77% | |
Immunomic Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Jan 14, 2021 | ||||
| Debt | Mar 15, 2017 | ||||
| Series A | Oct 28, 2014 | ||||
| Debt | Jul 17, 2013 | ||||
| Angel | Mar 5, 2012 |
Immunomic Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Life Sciences Greenhouse Investments | Debt |
| Keiretsu Forum | Debt |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 20, 2026
Open roles increased to 6, 3x the trailing average.
- Jan 14, 2021
$78M round led by HLB Co., Ltd.
Immunomic Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Immunomic Therapeutics's valuation, stock price, and market status.